{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:17:36Z","timestamp":1788898656499,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Type 2 Diabetes (T2D) imposes a disproportionate burden on the South Asian population. Their phenotype is characterized by heightened insulin resistance, even in individuals without overt T2D. Commonly used screening tools underestimate the T2D incidence in this population. The Metabolic syndrome (MetS) and the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) are indicators of insulin resistance; however, their predictive value for the development of T2D remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Among 698 initially enrolled healthy South Asian adults aged 30 to 65 in a Rotterdam-based cardiovascular disease prevention study, 270 participants were included after a 14-year follow-up. At baseline, an extensive history, physical examination, and metabolic screening were taken. A follow-up assessment of incident T2D was conducted. Multivariable logistic regression models calculated odds ratios (ORs) for MetS, its components, and HOMA-IR and adjusted for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>33 (12.2%) of participants developed T2D. The presence of MetS at baseline showed an adjusted OR of 2.6, (95% confidence interval (CI) 1.2\u20135.7, p\u2009=\u20090.02) for incident T2D. Fasting plasma glucose was the most strongly associated component of MetS (OR 3.0, CI 1.1\u20138.6, p\u2009=\u20090.04) HOMA-IR was also associated and showed an OR of 1.2 per point increase (CI 1.0\u20131.4, p=0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MetS and FPG were the most important predictors of T2D development in this South Asian cohort. These results underscore the value of diverse variables in T2D detection and give insight into which screening tools for T2D prediction should be used in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00592-025-02513-3","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T03:13:02Z","timestamp":1747019582000},"page":"1873-1880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A 14-year prospective cohort study of type 2 diabetes development in Dutch healthy adults of South Asian origin: risk factors and the association with metabolic syndrome and HOMA-IR"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6964-550X","authenticated-orcid":false,"given":"Sebastian B","family":"Beckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanti","family":"Bhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bruning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4831-4183","authenticated-orcid":false,"given":"T. Martijn","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9187-4130","authenticated-orcid":false,"given":"Sjaam","family":"Jainandunsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2513_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/1471-2458-12-380","volume":"12","author":"R Jayawardena","year":"2012","unstructured":"Jayawardena R et al (2012) Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health 12:380. https:\/\/doi.org\/10.1186\/1471-2458-12-380","journal-title":"BMC Public Health"},{"key":"2513_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/qjmed\/95.4.241","volume":"95","author":"TA Chowdhury","year":"2002","unstructured":"Chowdhury TA, Lasker SS (2002) Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM Int J Med 95:241\u2013246. https:\/\/doi.org\/10.1093\/qjmed\/95.4.241","journal-title":"QJM Int J Med"},{"key":"2513_CR3","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1210\/jcem.86.11.7992","volume":"86","author":"A Raji","year":"2001","unstructured":"Raji A, Seely EW, Arky RA, Simonson DC (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366\u20135371. https:\/\/doi.org\/10.1210\/jcem.86.11.7992","journal-title":"J Clin Endocrinol Metab"},{"key":"2513_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc05-2179","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of \u03b2-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130\u20131139. https:\/\/doi.org\/10.2337\/dc05-2179","journal-title":"Diabetes Care"},{"key":"2513_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00592-014-0588-9","volume":"52","author":"S Jainandunsing","year":"2015","unstructured":"Jainandunsing S et al (2015) Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes. Acta Diabetol 52:11\u201319. https:\/\/doi.org\/10.1007\/s00592-014-0588-9","journal-title":"Acta Diabetol"},{"key":"2513_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1210\/jcem.84.1.5371","volume":"84","author":"MA Banerji","year":"1999","unstructured":"Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE (1999) Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:137\u2013144. https:\/\/doi.org\/10.1210\/jcem.84.1.5371","journal-title":"J Clin Endocrinol Metab"},{"key":"2513_CR7","first-page":"629","volume":"131","author":"S Sandeep","year":"2010","unstructured":"Sandeep S, Gokulakrishnan K, Velmurugan K, Deepa M, Mohan V (2010) Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians. Indian J Med Res 131:629\u2013635","journal-title":"Indian J Med Res"},{"key":"2513_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0007114508073649","volume":"101","author":"A Misra","year":"2008","unstructured":"Misra A, Khurana L, Isharwal S, Bhardwaj S (2008) South Asian diets and insulin resistance. Br J Nutr 101:465\u2013473","journal-title":"Br J Nutr"},{"key":"2513_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/pubmed\/fdh158","volume":"26","author":"CM Fischbacher","year":"2004","unstructured":"Fischbacher CM, Hunt S, Alexander L (2004) How physically active are South Asians in the United Kingdom? A literature review. J Public Health 26:250\u2013258. https:\/\/doi.org\/10.1093\/pubmed\/fdh158","journal-title":"J Public Health"},{"key":"2513_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"ADAPP Committee","year":"2023","unstructured":"Committee ADAPP (2023) Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142024. Diabetes Care 47:S20\u2013S42. https:\/\/doi.org\/10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"key":"2513_CR11","unstructured":"Federatie ND (2023) Vroegopsporing, https:\/\/diabetesfederatie.nl\/ndf-toolkit-persoonsgerichte-diabeteszorg\/vroegopsporing. Accessed 26 Feb 2025"},{"key":"2513_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/0003-4819-151-11-200912010-00005","volume":"151","author":"P Heejung Bang","year":"2009","unstructured":"Heejung Bang P, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM (2009) Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med 151:775\u2013783. https:\/\/doi.org\/10.7326\/0003-4819-151-11-200912010-00005","journal-title":"Ann Intern Med"},{"key":"2513_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/14017431.2020.1821909","volume":"55","author":"KS Rabanal","year":"2021","unstructured":"Rabanal KS et al (2021) Validation of the cardiovascular risk model NORRISK 2 in South Asians and people with diabetes. Scand Cardiovasc J 55:56\u201362. https:\/\/doi.org\/10.1080\/14017431.2020.1821909","journal-title":"Scand Cardiovasc J"},{"key":"2513_CR14","unstructured":"Marshall EK (2003) Ontstaan en ontwikkeling van het Surinaams nationalisme. Natievorming als opgave PhD thesis, University of Amsterdam"},{"key":"2513_CR15","unstructured":"Barents ESE, BH, Bouma M, Dankers M, De Rooij A, Hart HE, Houweling ST, IJzerman RG, Janssen PGH, Kerssen A, Oud M, Palmen J, Van den Brink-Muinen A, Van den Donk M, Verburg-Oorthuizen AFE, Wiersma Tj (2023) Diabetes mellitus type 2. NHG-Richtlijnen. https:\/\/richtlijnen.nhg.org\/standaarden\/diabetes-mellitus-type-2. Accessed 26 Feb 2025"},{"key":"2513_CR16","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.1989.00390070054005","volume":"149","author":"NM Kaplan","year":"1989","unstructured":"Kaplan NM (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514\u20131520. https:\/\/doi.org\/10.1001\/archinte.1989.00390070054005","journal-title":"Arch Intern Med"},{"key":"2513_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/vhrm.s5172","volume":"5","author":"D Eapen","year":"2009","unstructured":"Eapen D, Kalra GL, Merchant N, Arora A, Khan BV (2009) Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag 5:731\u2013743. https:\/\/doi.org\/10.2147\/vhrm.s5172","journal-title":"Vasc Health Risk Manag"},{"key":"2513_CR18","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection (2002) Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"key":"2513_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/s0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome\u2013a new worldwide definition. Lancet 366:1059\u20131062. https:\/\/doi.org\/10.1016\/s0140-6736(05)67402-8","journal-title":"Lancet"},{"key":"2513_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40292-022-00542-5","volume":"29","author":"JG Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez JG et al (2022) HOMA-IR as a predictor of Health outcomes in patients with metabolic risk factors: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev 29:547\u2013564. https:\/\/doi.org\/10.1007\/s40292-022-00542-5","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2513_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0168-8227(03)00060-3","volume":"60","author":"A Ramachandran","year":"2003","unstructured":"Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V (2003) Metabolic syndrome in urban Asian Indian adults\u2014a population study using modified ATP III criteria. Diabetes Res Clin Pract 60:199\u2013204. https:\/\/doi.org\/10.1016\/S0168-8227(03)00060-3","journal-title":"Diabetes Res Clin Pract"},{"key":"2513_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/met.2009.0097","volume":"8","author":"E Flowers","year":"2010","unstructured":"Flowers E et al (2010) Prevalence of metabolic syndrome in South Asians residing in the United States. Metab Syndr Relat Disord 8:417\u2013423. https:\/\/doi.org\/10.1089\/met.2009.0097","journal-title":"Metab Syndr Relat Disord"},{"key":"2513_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jdiacomp.2018.08.001","volume":"32","author":"A Misra","year":"2018","unstructured":"Misra A et al (2018) Body fat, metabolic syndrome and hyperglycemia in South Asians. J Diabetes Complic 32:1068\u20131075. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.08.001","journal-title":"J Diabetes Complic"},{"key":"2513_CR24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2337\/dc06-2152","volume":"30","author":"G de Simone","year":"2007","unstructured":"de Simone G et al (2007) Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the strong heart study. Diabetes Care 30:1851\u20131856. https:\/\/doi.org\/10.2337\/dc06-2152","journal-title":"Diabetes Care"},{"key":"2513_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1538-7836.2007.02434.x","volume":"5","author":"R Ajjan","year":"2007","unstructured":"Ajjan R, Carter AM, Somani R, Kain K, Grant PJ (2007) Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost 5:754\u2013760. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02434.x","journal-title":"J Thromb Haemost"},{"key":"2513_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/ije\/dyw341","volume":"45","author":"J Textor","year":"2017","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Li\u015bkiewicz M, Ellison GT (2017) Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol 45:1887\u20131894. https:\/\/doi.org\/10.1093\/ije\/dyw341","journal-title":"Int J Epidemiol"},{"key":"2513_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"T Van der Weele","year":"2017","unstructured":"Van der Weele T, Ding P (2017) Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 167:268\u2013274. https:\/\/doi.org\/10.7326\/M16-2607","journal-title":"Ann Intern Med"},{"key":"2513_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.2337\/diacare.27.7.1728","volume":"27","author":"ES Tai","year":"2004","unstructured":"Tai ES et al (2004) Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728\u20131734. https:\/\/doi.org\/10.2337\/diacare.27.7.1728","journal-title":"Diabetes Care"},{"key":"2513_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2458-8-271","volume":"8","author":"NR Bindraban","year":"2008","unstructured":"Bindraban NR et al (2008) Prevalence of diabetes mellitus and the performance of a risk score among Hindustani Surinamese, African Surinamese and ethnic Dutch: a cross-sectional population-based study. BMC Public Health 8:271. https:\/\/doi.org\/10.1186\/1471-2458-8-271","journal-title":"BMC Public Health"},{"key":"2513_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003981","volume":"19","author":"S Hodgson","year":"2022","unstructured":"Hodgson S et al (2022) Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: a population-based cohort study. PLoS Med 19:e1003981. https:\/\/doi.org\/10.1371\/journal.pmed.1003981","journal-title":"PLoS Med"},{"key":"2513_CR31","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/dc13-2101","volume":"37","author":"M Porta","year":"2014","unstructured":"Porta M et al (2014) Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence. Diabetes Care 37:1668\u20131674. https:\/\/doi.org\/10.2337\/dc13-2101","journal-title":"Diabetes Care"},{"key":"2513_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL et al (2022) Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab Syndr 16:102581. https:\/\/doi.org\/10.1016\/j.dsx.2022.102581","journal-title":"Diabetes Metab Syndr"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02513-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:07:09Z","timestamp":1764180429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02513-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2513"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02513-3","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sebastian Beckmann does not report any conflicts of interest. Priyanti Bhawan does not report any conflicts of interest. Tobias Bruning: does not report any conflicts of interest. T. Martijn Kuijper does not report any conflicts of interest. Sjaam Jainandunsing does not report any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the medical ethical committee (CCMO, ID: NL24276.101.09).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}